
Sign up to save your podcasts
Or


The Food and Drug Administration is currently considering MDMA as a treatment for post-traumatic stress disorder. Anna Silman, features correspondent at Business Insider, breaks down her reporting on the decades-long fight to legalize the drug and why some pro-MDMA advocates are sounding the alarm.
By WNYC4.6
15071,507 ratings
The Food and Drug Administration is currently considering MDMA as a treatment for post-traumatic stress disorder. Anna Silman, features correspondent at Business Insider, breaks down her reporting on the decades-long fight to legalize the drug and why some pro-MDMA advocates are sounding the alarm.

38,498 Listeners

6,789 Listeners

9,192 Listeners

8,486 Listeners

4,049 Listeners

479 Listeners

12,684 Listeners

14,461 Listeners

6,408 Listeners

1,541 Listeners

3,511 Listeners

111,918 Listeners

2,801 Listeners

1,405 Listeners

32,326 Listeners

1,196 Listeners

5,567 Listeners

5,769 Listeners

422 Listeners

189 Listeners

7,222 Listeners

665 Listeners

15,794 Listeners

2,822 Listeners

645 Listeners

1,970 Listeners

91 Listeners

84 Listeners

619 Listeners

57 Listeners

204 Listeners

20 Listeners